Navigation Links
NxStage Celebrates Seven Year Anniversary of IU Health's Home Hemodialysis Program and Patient Milestones
Date:8/15/2011

LAWRENCE, Mass., Aug. 15, 2011 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, is celebrating Indiana University Health's (IU Health) seventh anniversary of its program to offer home hemodialysis to patients with the NxStage System One™.  IU Health started its home dialysis program by partnering with NxStage on its Investigational Device Exemption (IDE) study for U.S. Food and Drug Administration (FDA) clearance to market the System One for home use. In addition, three IU Health patients who were among the first ever to receive dialysis with the System One, are celebrating more than seven years with the therapy.

(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO)

Long-time dialysis patient Rick Skiles, 57, had tried numerous treatment modalities when he learned about NxStage's clinical trial study at IU Health in 2004. Skiles enrolled and became the first patient in Indiana to train on the NxStage System One. More than seven years later, the flexibility to do his treatments on his own time and the health benefits he has realized thanks to more frequent treatments have helped Skiles lead a liberated, healthy life. "I feel extremely fortunate as a patient at IU Health to have had the opportunity to be among the first daily home hemodialysis patients," says Skiles. "With the System One, I felt I got my life back, and I look forward to many active, healthy years to come with this therapy."

"We applaud healthcare providers and partners such as IU Health for helping to pioneer daily home hemodialysis with the NxStage System One," said Jeffrey H. Burbank, Chief Executive Officer of NxStage Medical. "Because of their leadership, enthusiasm, and continued commitment to advancing renal care, a growing number of dialysis patients like Rick are realizing the life-changing benefits po
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NxStage(R) to Recognize Several Key Milestones at American Society of Nephrologys Renal Week 2007
2. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
3. NxStage(R) to Report Third Quarter 2009 Financial Results
4. NxStage(R) Reports Significant Interim FREEDOM Study Results
5. NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
6. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
7. Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM)
8. NxStage(R) Secures $15 Million Revolving Line of Credit
9. NxStage to Report Third Quarter Fiscal 2010 Financial Results
10. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
11. NxStage Announces Fourth Quarter 2010 Investor Conference Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... DUBLIN , July 11, 2014 ... the addition of the "Immunoprotein Diagnostic Testing ... at the highest CAGR of 6% and is ... report to their offering. ... for immunoprotein diagnostic testing has been segmented according ...
(Date:7/10/2014)... India , July 11, 2014  Major ... treatment of cancer are being highlighted in a ... Mumbai from 10-12 July, 2014.  Renowned national ... to share best practices and exchange knowledge on ... precise, accurate and efficient. The ...
(Date:7/10/2014)... July 10, 2014 Integrated Silicon Solution, Inc. ... memory and analog IC solutions, today announced that it ... 24, 2014, at 7:00 a.m. Pacific Time (10:00 a.m. ... the fiscal 2014 third quarter ended June 30, 2014. ... dial 1-888-556-4997 before 6:50 a.m. Pacific time on July ...
Breaking Medicine Technology:Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5
... CINCINNATI, June 10, 2011 To address the need ... treat a variety of patient needs, Ethicon Endo-Surgery (EES), ... broadest spectrum of bariatric surgical solutions and innovative technologies ... (ASMBS) 28th Annual Meeting at the Gaylord Hotel and ...
... N.J., June 10, 2011 Insmed Incorporated (Nasdaq ... data through six treatment cycles (72 weeks total ... for ARIKACE® (liposomal amikacin for inhalation) in cystic ... infections.  The data were presented at the 34th ...
Cached Medicine Technology:Ethicon Endo-Surgery to Showcase Broadest Spectrum of Innovative Bariatric Surgical Options, Physician Best Practices and Mobile/Web-Based After-Care Patient Programs at ASMBS 2Ethicon Endo-Surgery to Showcase Broadest Spectrum of Innovative Bariatric Surgical Options, Physician Best Practices and Mobile/Web-Based After-Care Patient Programs at ASMBS 3Ethicon Endo-Surgery to Showcase Broadest Spectrum of Innovative Bariatric Surgical Options, Physician Best Practices and Mobile/Web-Based After-Care Patient Programs at ASMBS 4Ethicon Endo-Surgery to Showcase Broadest Spectrum of Innovative Bariatric Surgical Options, Physician Best Practices and Mobile/Web-Based After-Care Patient Programs at ASMBS 5Ethicon Endo-Surgery to Showcase Broadest Spectrum of Innovative Bariatric Surgical Options, Physician Best Practices and Mobile/Web-Based After-Care Patient Programs at ASMBS 6Insmed's ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections 2Insmed's ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections 3Insmed's ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections 4Insmed's ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections 5Insmed's ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections 6
(Date:7/14/2014)... New research and analysis from the national ... examines toxic ingredients in tampons, a product used ... chemicals that may be found in the product’s absorptive ... put women’s health at risk. , According to ... , the potential impact of toxic chemical exposure from ...
(Date:7/13/2014)... (PRWEB) July 14, 2014 FORT LEE, N.J. ... tackle the modern approach to the science of tooth ... Implant. This book describes recent advances and techniques ... methodological approaches that benefit people who have lost all of ... inserted the first lower subperiosteal implant in 1940. ...
(Date:7/13/2014)... MA (PRWEB) July 14, 2014 MED-Ed ... presenting at our next conference, April 7+8 in Boston ... well attended at the recent event. Presentations by individuals ... 2014. , To review the types of sessions that ... , Submit your proposal today! , Conference ...
(Date:7/13/2014)... 14, 2014 Worldwide ladies are extremely ... Angeldress.co.uk has taken a different approach and has created ... are offered in more colour choices that responded directly ... brand of women’s special occasion apparels. The company’s pink ... specialists are working hard to create the best products ...
(Date:7/13/2014)... July 13, 2014 Ticket Down ... Madrid Tickets . For the fifth straight year (and ... will be held at American stadiums this summer. The tournament ... American soil. The eight teams are split into two groups ... the top two teams will compete to become champion. One ...
Breaking Medicine News(10 mins):Health News:New Patent Analysis Shows Toxic Risk From Tampons 2Health News:New Patent Analysis Shows Toxic Risk From Tampons 3Health News:New Patent Analysis Shows Toxic Risk From Tampons 4Health News:New Patent Analysis Shows Toxic Risk From Tampons 5Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 2Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 3Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 4Health News:MED-Ed Facilities Conference Call for Speakers Open 2Health News:Angeldress.co.uk Announces Summer Sale For Pink And Red Bridesmaid Dresses; The Current Discount Is Up To 80% Off 2Health News:AS Roma vs Real Madrid Tickets in Dallas at Cotton Bowl: Ticket Down Slashes Ticket Prices for Real Madrid vs AS Roma Guinness International Champions Cup Match 2Health News:AS Roma vs Real Madrid Tickets in Dallas at Cotton Bowl: Ticket Down Slashes Ticket Prices for Real Madrid vs AS Roma Guinness International Champions Cup Match 3
... Genomatix Software Inc., the newly incorporated subsidiary of Genomatix Software ... software licensing agreement with the NCI/NIH for the fourth consecutive ... history as the renewal was executed entirely between the US ... We are extremely pleased with our progress in putting the ...
... Rice University Psychology Professor Tony Ro has published its ... as synesthesia, in which stimulation of one sensory pathway ... pathway. , Ro,s paper, Feeling Sounds After a Thalamic ... the official journal of the American Neurological Association. The ...
... - Researchers at the Centre for Addiction and Mental ... and the risk of head and neck cancers, showing ... cancer risk. , According to CAMH Principal Investigator ... between alcohol consumption and an increased risk for cancer ...
... Drug Discovery Projects, REDWOOD CITY, Calif., Sept. ... announced today that it has obtained,commitments from several ... its common stock and warrants to purchase,approximately 2.6 ... proceeds of,approximately $23.7 million. The investors have agreed ...
... form of care, experts say , WEDNESDAY, Sept. ... issued new "performance measures" meant to boost patient enrollment ... heart attack patients aren,t getting the benefit of this ... set standards of excellence for these programs and are ...
... The close of summer traditionally,marks the return to ... fall,and holiday baking seasons. This year, in response to ... cooking is a growing,trend. A study published in the ... in kids, body mass index occur during the summer,months, ...
Cached Medicine News:Health News:Research at Rice may help explain aspects of synesthesia 2Health News:Research at Rice may help explain aspects of synesthesia 3Health News:Alcohol and cancer: is drinking the new smoking? 2Health News:Genelabs Technologies Announces Commitments to Raise $23.7 Million in a Registered Direct Financing 2Health News:Heart Attack Survivors Benefit From Rehab 2Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 2Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 3Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 4
... complete line of enteric disease ... and monoclonal/polyclonal antibody-based ELISA tests ... pathogens in fecal specimens. Our ... difficile, Entamoeba histolytica, Giardia, Cryptosporidium ...
... II test is also available with Inverness ... greatly reduces the hands-on time required to ... testing. The Fecal-Quik-Prep device is a unique ... amount of hands-on time required to prepare ...
... for autoimmune testing feature single-well ANA screen ... specific reflex tests including dsDNA, and 6 ... SS-B (La), Scl-70 and Jo-1. In addition, ... line of products for Cardiolipins (IgA, IgG, ...
... Our ELISA products for autoimmune testing ... ELISAs, as well as specific reflex tests ... Sm, Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 ... family includes a full line of products ...
Medicine Products: